Toll-like receptor-3 and the regulation of intrahepatic immunity: Implications for interferon-alpha therapy

Hepatology

Volumn 45, Issue 1, 2007, Pages 250-251

  Bertolino, Patrick ^a   Holz, Lauren E ^a  

^a CENTENARY INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA;

CD8+ T LYMPHOCYTE; CELL INFILTRATION; IMMUNE DEFICIENCY; INFLAMMATION; INNATE IMMUNITY; LIVER INJURY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 33846425293     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21504     Document Type: Note

References (9)

1. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003;3: 51-62.
2. Limmer A, Sacher T, Alferink J, Kretschmar M, Schonrich G, Nichterlein T, et al. Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment. Eur J Immunol 1998;28: 2395-2406.
3. Bowen DG, Zen M, Holz L, Davis T, McCaughan GW, Bertolino P. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 2004;114:701-712.
4. Lang KS, Georgiev P, Recher M, Navarini AA, Bergthaler A, Heikenwalder M, et al. Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest 2006;116:2456-2463.
5. Frigerio S, Junt T, Lu B, Gerard C, Zumsteg U, Hollander GA, Piali L. Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med 2002;8:1414-1420.
6. Curbishley SM, Eksteen B, Gladue RP, Lalor P, Adams DH. CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am J Pathol 2005;167:887-899.
7. Shiow LR, Rosen DB, Brdickova N, Xu Y, An J, Lanier LL, Cyster JG, et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006;440:540-544.
8. Lorke J, Erhardt A, Haussinger D. Induction of autoimmune hepatitis by pegylated interferon alfa-2b in chronic hepatitis C. Clin Gastroenterol Hepatol 2004;2:A20.
9. Kontorinis N, Agarwal K, Elhajj N, Fiel MI, Schiano TD. Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transpl 2006;12:827-830.